Andrei C Sposito
Overview
Explore the profile of Andrei C Sposito including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
221
Citations
2614
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barthold S, Minin E, Carvalho-Romano L, Marques E, Paim L, Lopes E, et al.
Vasc Med
. 2025 Mar;
:1358863X251323516.
PMID: 40028707
No abstract available.
2.
Koeche C, Nogueira A, Amaral G, Guimaraes A, Neiva Y, de Souza A, et al.
Value Health Reg Issues
. 2025 Feb;
47:101084.
PMID: 39946962
Objectives: Mineralocorticoid receptor antagonists (MRAs) are cornerstones in the management of heart failure (HF) with reduced ejection fraction (HFrEF). New MRAs with improved safety profile, such as finerenone and eplerenone,...
3.
Bezerra R, Gorayeb-Polacchini F, Teles F, Pinto L, Tome A, Bidoia M, et al.
Hypertens Res
. 2025 Jan;
48(3):1169-1173.
PMID: 39814967
In hemodialysis patients, blood pressure (BP) measured at the postdialysis period (POSBP) can be used to diagnose hypertension. However, the optimal time point for POSBP remains uncertain. This cross-sectional study...
4.
Cavalcante P, Barreto J, Kimura-Medorima S, Breder I, Nadruz W, Sposito A
Curr Med Res Opin
. 2024 Dec;
41(1):25-29.
PMID: 39706688
Background: White coat effect (WCE) is a phenomenon linked to increased cardiovascular risk, where office blood pressure readings exceed home or ambulatory measurements. Excess weight and elevated blood pressure or...
5.
Alves M, Bezerra R, Dal Pont C, Mota-Gomes M, Paiva A, Barroso W, et al.
J Hypertens
. 2024 Nov;
43(3):456-463.
PMID: 39526675
Objective: Home blood pressure (BP) variability (BPV) and BP phenotypes such as white-coat hypertension (WCH), white-coat uncontrolled hypertension (WUCH), masked hypertension (MH) and masked uncontrolled hypertension (MUCH) are predictors of...
6.
Dal Pont C, Argenta F, Bezerra R, Viana G, Starke S, Azevedo G, et al.
Hypertens Res
. 2024 Oct;
48(1):398-401.
PMID: 39472545
This study investigated the prevalence of white-coat hypertension (WCH) among individuals with office isolated systolic hypertension (ISH), isolated diastolic hypertension (IDH), and systolic-diastolic hypertension (SDH). We evaluated 9122 individuals [57.0 ...
7.
Carmo H, Castillo A, Bonilha I, Gomes E, Barreto J, Moura F, et al.
Front Pharmacol
. 2024 Oct;
15:1402032.
PMID: 39434905
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is linked to high mortality, primarily through an intense inflammatory response. Diacerein has emerged as a potential therapy for COVID-19 due to...
8.
Diniz P, Bezerra R, Feitosa C, Goncalves T, Paiva A, Mota-Gomes M, et al.
Hypertens Res
. 2024 Oct;
47(12):3473-3479.
PMID: 39379464
The association between diabetes mellitus (DM) and masked hypertension (MH) in ambulatory blood pressure (BP) monitoring is established, but its relationship with home BP monitoring (HBPM) remains uncertain. This web-based...
9.
Barreto J, Martins M, Pascoa M, Medorima S, Bonilha I, Jesus D, et al.
Expert Opin Drug Saf
. 2024 Oct;
:1-7.
PMID: 39377184
Background: Dapagliflozin prevents myocardial dysfunction in chronic kidney disease patients regardless of residual kidney function. We hypothesized that this effect is extensible also to patients on dialysis. Research Design And...
10.
Paiva A, Gomes M, Gomes A, Gomes L, Ramalho S, Feitosa A, et al.
J Hypertens
. 2024 Oct;
43(2):264-270.
PMID: 39351851
Objective: Interarm systolic blood pressure difference (IASD) values >15 mmHg (IASD > 15) are associated with increased cardiovascular risk, yet the underlying mechanisms remain unclear. This report evaluated whether IASD...